Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Lund, Troy C ^a   Stadem, Paul S ^a   Panoskaltsis Mortari, Angela ^a   Raymond, Gerald ^b   Miller, Weston P ^a   Tolar, Jakub ^a   Orchard, Paul J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 2BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADRENOLEUKODYSTROPHY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHOOL CHILD; SCORING SYSTEM; CEREBROSPINAL FLUID; DISEASE COURSE; HOSPITALIZATION;

ADRENOLEUKODYSTROPHY; CHEMOKINE CCL4; CHILD; CYTOKINES; DISEASE PROGRESSION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-8; MAGNETIC RESONANCE IMAGING; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84857132160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032218     Document Type: Article

References (29)

1. Ferrer I, Aubourg P, Pujol A, (2010) General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 20: 817-830.
2. Peters C, (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104: 881-888.
3. Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, et al. (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis 14: 425-439.
4. Deon M, Wajner M, Sirtori L, Fitarelli D, Coelho D, et al. (2006) The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy. Journal of the Neurological Sciences 247: 157-164.
5. Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, et al. (2000) Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356: 713-718.
6. Hudspeth MP, Raymond GV, (2007) Immunopathogenesis of adrenoleukodystrophy: current understanding. Journal of Neuroimmunology 182: 5-12.
7. McGuinness MC, Powers JM, Bias WB, Schmeckpeper BJ, Segal AH, et al. (1997) Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. Journal of Neuroimmunology 75: 174-182.
8. McGuinness MC, Griffin DE, Raymond GV, Washington CA, Moser HW, et al. (1995) Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy. J Neuroimmunol 61: 161-169.
9. Powers JM, Liu Y, Moser AB, Moser HW, (1992) The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 51: 630-643.
10. Orchard PJ, Lund T, Miller W, Rothman SM, Raymond G, et al. (2011) Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation 8: 144.
11. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, et al. (1994) Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 15: 1761-1766.
12. Phillips JP, Lockman LA, Shapiro EG, Blazar BR, Loes DJ, et al. (1994) CSF findings in adrenoleukodystrophy: correlation between measures of cytokines, IgG production, and disease severity. Pediatr Neurol 10: 289-294.
13. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH, (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
14. Lau TT, Wang DA, (2011) Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11: 189-197.
15. Moll NM, Cossoy MB, Fisher E, Staugaitis SM, Tucky BH, et al. (2009) Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol 66: 44-53.
16. Wang A, Fairhurst AM, Tus K, Subramanian S, Liu Y, et al. (2009) CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol 182: 4448-4458.
17. Zajkowska J, Moniuszko-Malinowska A, Pancewicz SA, Muszynska-Mazur A, Kondrusik M, et al. (2011) Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE). Adv Med Sci pp. 1-7.
18. Mennicken F, Maki R, de Souza EB, Quirion R, (1999) Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20: 73-78.
19. Hallegua DS, Weisman MH, (2002) Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 61: 960-967.
20. Casal JA, Robles A, Tutor JC, (2003) Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementia. Clin Biochem 36: 553-556.
21. Hollak CE, van Weely S, van Oers MH, Aerts JM, (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93: 1288-1292.
22. Gerard C, Rollins BJ, (2001) Chemokines and disease. Nat Immunol 2: 108-115.
23. Sotgiu S, Barone R, Arru G, Fois ML, Pugliatti M, et al. (2006) Intrathecal chitotriosidase and the outcome of multiple sclerosis. Mult Scler 12: 551-557.
24. Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, et al. (2008) Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 63: 729-742.
25. Arend WR, (2002) The balance between IL-1 and IL-1Ra in disease. Cytokine & Growth Factor Reviews 13: 323-340.
26. Polgreen LE, Chahla S, Miller W, Rothman S, Tolar J, et al. (2011) Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes. European journal of pediatrics.
27. Miller WP, Rothman SM, Nascene D, Kivisto T, Defor TE, et al. (2011) Outcomes following allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood.
28. Koehne P, Hochhaus F, Felderhoff-Mueser U, Ring-Mrozik E, Obladen M, et al. (2002) Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery 18: 137-141.
29. Charo IF, Ransohoff RM, (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621.